Impact of MRI-based planning in transperineal interstitial brachytherapy for locally advanced cervix tumors: Clinical, dosimetric and toxicity outcomes

被引:0
|
作者
Barrera, Diana Guevara [1 ,2 ]
Villalba, Silvia Rodriguez [2 ]
Suso-Marti, Luis [3 ]
Sanchis-Sanchez, Enrique [3 ]
Perez-Calatayud, Jose [2 ,4 ]
Martin, Jose Domingo Lago [2 ,5 ]
Molina, Francisco Blazquez [2 ]
Ortega, Manuel Santos [2 ]
机构
[1] Catholic Univ Valencia San Vicente Martir, Doctoral Sch, Valencia, Spain
[2] Hosp Clin Benidorm, Radiat Oncol Dept, Alicante, Spain
[3] Univ Valencia, Dept Physiotherapy, Exercise Intervent Hlth Res Grp EXINH RG, Valencia, Spain
[4] La Fe Univ & Polytech Hosp, Radiat Oncol Dept, Valencia, Spain
[5] Hosp Vithas Virgen del Consuelo, Radiat Oncol Dept, Valencia, Spain
关键词
Cervical cancer; HDR; Interstitial brachytherapy; MRI-guided brachytherapy; DOSE-RATE BRACHYTHERAPY; GUIDED ADAPTIVE BRACHYTHERAPY; SOCIETY CONSENSUS GUIDELINES; COMPUTED-TOMOGRAPHY; CANCER BRACHYTHERAPY; ADVANCED-CARCINOMA; AMERICAN BRACHYTHERAPY; COMBINED INTRACAVITARY; TEMPLATE; RECOMMENDATIONS;
D O I
10.1016/j.brachy.2024.10.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE: To compare dosimetric characteristics, clinical outcomes, and toxicity in patients with locally advanced cervical cancer(LACC) treated with transperineal interstitial brachytherapy(PISBT), using CT-based planning or MRI-based planning with a monoinstitutional MRI-compatible applicator, Template Benidorm(TB). MATERIALS AND METHODS: We retrospectively analyzed 106 women treated with P-ISBT for LACC from 2006 to 2022. P-ISBT was CT-based, with Martinez Universal Perineal Interstitial Template(MUPIT) between 2006 and 2012, or MRI-based planning (TB) since 2013. Volumetric, clinical, and dosimetric parameters were compared between applicators. RESULTS: Forty-six (43.4%) patients were treated with MUPIT, and 60 (56.6%) with TB. Median follow-up was 42 months (4-188). No significant difference was observed in 5-year local control (LC), regional control (RC), distant failure (DF), overall survival (OS), and disease-specific survival (DSS) between applicators. The TB cohort had fewer needles ( p = 0.001 ), halved median CTV volume ( p < 0.001 ), increased median D90%CTV dose ( p < 0.005 ), and lower D2cc values in rectum/bladder ( p < 0.001 ). G3 chronic toxicity was 15% in the MUPIT group and 6% in TB ( p = 0.15 ), with no G4 toxicity reported. Rectal hemorrhage was lower in the TB group ( p = 0.002 ). Larger CTV volumes correlated with higher rectal D2cc and rectal hemorrhage ( p = 0.001 ; p = 0.029 , respectively), and enterovaginal fistula ( p = 0.03; p < 0.001 , respectively). Median CTV volume was 152.82 cc (35.3-256.78) in patients with chronic rectal toxicity and 102.9 cc (21.4-329.41) in those without ( p = 0.001 ). CONCLUSION: MRI's superior CTV-volume definition results in smaller treatment volumes, lower D2ccfor rectum and bladder, and a trend towards higher CTV D-90% . Rectal hemorrhage was significantly lower in the MRI-based group. A significant correlation was observed between larger CTV-volumes, higher rectal D2cc and rectal hemorrhage/enterovaginal fistula. (c) 2024 American Brachytherapy Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:134 / 143
页数:10
相关论文
共 50 条
  • [21] Clinical outcome and late toxicity of MRI-based brachytherapy in cervical cancer patients
    Poksawat, K.
    Alisanant, P.
    Amornwichet, N.
    Shotelersuk, K.
    Khorprasert, C.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S1227 - S1227
  • [22] Single Institute Experience with MRI-Guided Adaptive Brachytherapy for Locally Advanced Cervix Cancer: Long Term Outcomes and Toxicity Analysis
    Cooper, S.
    Gupta, M.
    Sim, V. R.
    Mullasery, V.
    Winship, A.
    Taylor, B.
    White, I.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E508 - E508
  • [23] Clinical outcome and toxicity of MRI-based vaginal cuff brachytherapy in endometrial cancer
    Jaisawang, C.
    Alisanant, P.
    Shotelersuk, K.
    Khorprasert, C.
    Amornwichet, N.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S807 - S808
  • [24] Hybrid brachytherapy in Locally advanced cervical cancers-Dosimetric study and clinical outcomes.
    Sharma, J.
    Chakraborty, S.
    Bhattacharyya, T.
    Maity, S.
    CLINICAL ONCOLOGY, 2024, 36 (09) : E368 - E368
  • [25] MRI-based brachytherapy treatment planning for cervix cancer using the (GYN) GEC-ESTRO recommendations
    Zwahlen, D.
    Jezioranski, J.
    Chan, P.
    Cho, Y-B.
    Guignard, C.
    Yeung, I.
    Manchul, L.
    Levin, W.
    Fyles, A.
    Milosevic, M.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S79 - S79
  • [26] Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients
    Koh, Vicky
    Choo, Bok Ai
    Lee, Khai Mun
    Tan, Teng Hwee
    Low, Jen Hui Jeffrey
    Ng, Soon Yau Joseph
    Ilancheran, Arunachalam
    Shen, Liang
    Tang, Johann
    BRACHYTHERAPY, 2017, 16 (01) : 126 - 132
  • [27] Impact of combined interstitial and intracavitary brachytherapy in locally advanced cervical cancer: A survival and toxicity profile assessment
    Pareek, V.
    Chandra, M.
    Bhalavat, R.
    ANNALS OF ONCOLOGY, 2019, 30 : 428 - 428
  • [28] Impact of combined interstitial and intracavitary brachytherapy in locally advanced cervical cancer: A survival and toxicity profile assessment
    Pareek, V.
    Bhalavat, R.
    Chandra, M.
    ANNALS OF ONCOLOGY, 2019, 30
  • [29] Clinical Implementation of MRI-Based Planning Without Dedicated MRI Simulator for Cervical Cancer HDR Brachytherapy
    Yang, K.
    Lawrence, L. de Souza
    Jacob, D.
    Mourtada, F.
    MEDICAL PHYSICS, 2018, 45 (06) : E467 - E467
  • [30] Proton Beam Therapy for Locally Advanced Head and Neck Tumors An Analysis of Dosimetric and Clinical Outcomes
    Sheikh, Saad
    Kharouta, Michael Z.
    Pidikiti, Rajesh
    Damico, Nicholas J.
    Choi, Serah
    Dorth, Jennifer A.
    Mansur, David B.
    Machtay, Mitchell X.
    Yao, Min
    Bhatt, Aashish D.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2022, 45 (02): : 81 - 87